India, Feb. 18 -- The share of this company, which offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours, gained investor traction after a significant stake changed hands.

With a market capitalization of Rs 12,427 crore, Cohance Lifesciences Ltd's shares on Wednesday made a day high of Rs 307.70 per share, up by 11.1 percent from the previous day's close price of Rs 307.70 per share. The share of the company trades at a way overvalued P/E of 41.2x compared to the industry P/E of 27.9x.

What Happened In a significant block deal, about 70 lakh shares of Cohance Lifesciences were traded, accounting for nearly 1.82 percent of the company's total equity. The transaction was valued at ro...